Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
33 results
D3.121 - Evaluation of small airway dysfunction in severe asthma treated with anti-IgE and anti-eosinophilic therapies: A prospective comparative study
D3.109 - Clinical Characteristics of Asthma Patients with Fungal Sensitization: A Retrospective Cross-Sectional Study
D3.110 - Patterns of Opioid or Neuromodulator Use in Chronic Cough Patients with Newly Diagnosed Asthma
D3.111 - The Impact of War on the Course of Asthma
D3.112 - Clinical Characteristics and Evaluation of Serum Inflammatory Markers in Patients Hospitalized Due to Asthma Exacerbations
D3.113 - The Diagnostic Value of Exercise Bronchial Provocation Testing in Pediatric Asthma
D3.114 - Characterization on genome-wide profile of H3K4me2 histone methylation in mouse asthmatic lung induced by Alt a 1
D3.115 - Iloprost Attenuates Neutrophilic Airway Inflammation in a Murine Model of Type 2-Low Asthma
D3.119 - Saving the Caregiver: Humanitarian Access to Dupilumab in a Physician with Severe Non-Allergic T2 Asthma in a Frontline Ukrainian City
D3.120 - Delivering Severe Asthma Care in the Real World: Insights into Anti-TSLP (Tezepelumab) Use from a Tertiary Allergy and Respiratory Centre
D3.122 - Real-World Outcomes Of Tezepelumab In Severe Asthma After 12 Months Of Treatment
D3.123 - The complementary role of impulse oscillometry in prediction of asthma persistance at school age among preschool children with recurrent wheezing
D3.124 - Effect of psycho-behavioural comorbidities on asthma symptom control scores: implications on asthma remission assessment
D3.108 - Heterogeneity of Remission Definitions in Asthma and Other Chronic Diseases: Evidence From Two Systematic Reviews
D3.126 - Evaluation of Severe Pediatric Asthma Response to Biologics Using the Pediatric CONFiRM Score: A Real-Life Cohort Analysis
D3.127 - Evaluation of Serum Ezrin Levels and Spirometric and Plethysmographic Tests in Patients with Allergic and Non-Allergic Asthma
D3.128 - Management of Nasal Polyposis in Moderate-Severe Asthma Patients With Aspirin Desensitization And Biologic Agent Combination: Our Real-Life Experience With Seven Cases
D3.129 - Evaluation of Cardiovascular Disease Risk and Associated Factors in Childhood Asthma
D3.130 - PGI2 Signaling Attenuates the Proliferation and Type 2 Cytokine Production of Group 2 Innate Lymphoid Cells
D3.131 - Comparative Assessment of Exercise Provocation, and Impulse Oscillometry in Young Adults With Exercise-Induced Respiratory Symptoms
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download